-
摘要:
食管胃肠道间质瘤生物学行为较胃肠道间质瘤差，以手术治疗为主，包括内镜下治疗、肿瘤摘除术以及食管部分切除术等。内镜下治疗包括内镜黏膜下剥离术（ESD）、内镜黏膜下隧道肿瘤切除术（STER）。随着微创技术的不断发展和成熟，本着创伤最小、疗效最大的原则，对食管胃肠道间质瘤的手术治疗方式值得进一步深入探讨。近年来，包括新辅助治疗和术后辅助治疗的分子靶向治疗成为胃肠道间质瘤治疗的一大进步，分子靶向治疗的成功开创了肿瘤分子靶向治疗的一个新时代。
Abstract:The biological behavior of esophageal gastroiontestinal stromal tumors is worse than that of gastrointestinal stromal tumors (GIST), so surgical treatment is the main treatment. The operative methods include endoscopic therapy, tumor enucleation and partial resection of the esophagus. Endoscopic treatment methods include endoscopic submucosal dissection (ESD) and submucosal tunnelling endoscopic resection (STER). With the development and maturity of minimally invasive technology, surgical treatment of esophageal GIST is worth further discussion based on the principle of minimal trauma and the best curative effect. In recent years, molecular targeted therapy, including neoadjuvant therapy and postoperative adjuvant therapy, has become a major advance in the treatment of GIST. The success of molecular targeted therapy opens a new era in the molecular targeted therapy of cancer.
-
Key words:
- Esophageal /
- Gastrointestinal stromal tumors /
- Surgical treatment /
- Targeted therapy
-
-
[1] Xu C, Han H, Wang J, et al. Diagnosis value of CD117 and PDGFRA, alone or incombination DOG1, as biomarkers for gastrointestinal stromal tumors[J]. Ann Transl Med, 2015, 3(20): 308. https://www.researchgate.net/publication/287995494_Diagnosis_value_of_CD117_and_PDGFRA_alone_or_in_combination_DOG1_as_biomarkers_for_gastrointestinal_stromal_tumors
[2] Søreide K, Sandvik OM, Søreide JA, et al. Global epidemiology of gastrointestinal stromal tumours (GIST): A systematic review of population-based cohort studies[J]. Cancer Epidemiol, 2016, 40: 39-46. doi: 10.1016/j.canep.2015.10.031
[3] Feng F, Tian Y, Lin Z, et al. Clinicopathologic features and clinical outcomes of esophageal gastrointestinal stromal tumor: evaluation of a pooled case series[J]. Medicine (Baltimore), 2016, 95(2): e2446. doi: 10.1097/MD.0000000000002446
[4] Borgaonkar V, Deshpande S, Borgaonkar V, et al. Gastrointestinal Stromal Tumor-Single-Center Experience with Review of the Literature[J]. Indian J Surg, 2015, 77(2): 678-81. https://www.researchgate.net/publication/271960057_Gastrointestinal_Stromal_Tumor-Single-Center_Experience_with_Review_of_the_Literature
[5] Alecu L, Tulin A, Enciu O, et al. Gastrointestinal Stromal Tumors-Diagnosisand Surgical Treatment[J]. Chirurgia (Bucur), 2015, 110(6): 525-9. https://www.researchgate.net/publication/288817038_Gastrointestinal_Stromal_Tumors_-_Diagnosis_and_Surgical_Treatment
[6] Güler B, Özyılmaz F, Tokuç B, et al. Histopathological Features of Gastrointestinal Stromal Tumors and the Contribution of DOG1 Expression to the Diagnosis[J]. Balkan Med J, 2015, 32(4): 388-96. doi: 10.5152/balkanmedj.
[7] lorio N, Sawaya RA, Friedenberg FK. Review article: the biology, diagnosis and management of gastrointestinal stromal tumours[J]. Aliment Pharmacol Ther, 2014, 39(12): 1376-86. doi: 10.1111/apt.2014.39.issue-12
[8] 沈坤堂, 高晓东.小和微小胃肠间质瘤的评估与内镜治疗[J].中华胃肠外科杂志. 2015, 18(4): 328-31. http://cdmd.cnki.com.cn/Article/CDMD-12121-1016269742.htm Shen KT, Gao XD. Evaluation and endoscopic treatment of small and micro gastrointestinal stromal tumors[J]. Zhonghua Wei Chang Wai Ke Za Zhi, 2015, 18(4): 328-31. http://cdmd.cnki.com.cn/Article/CDMD-12121-1016269742.htm
[9] 余昌中, 张维一, 柰超, 等.腹腔镜、胃镜联合手术治疗胃间质瘤48例临床分析[J].肿瘤防治研究, 2014, 41(2): 157-9. doi: 10.3971/j.issn.1000-8578.2014.02.015 Yu CZ, Zhang WY, Nai C, et al. Clinical analysis of 48 patients with gastric stromal tumor treated by laparoscopic combined with gastroscopic resection[J]. Zhong Liu Fang Zhi Yan Jiu, 2014, 41(2): 157-9. doi: 10.3971/j.issn.1000-8578.2014.02.015
[10] Nakano A, Akutsu Y, Shuto K, et al. Giant esophageal gastrointestinal stromal tumor: report of a case[J]. Surg Today, 2015, 45(2): 247-52. doi: 10.1007/s00595-014-0929-x
[11] Constantinoiu S, Gheorghe M, Popa L, et al. Giant Esophageal GIST: Diagnostic and Therapeutic Challenge-Case Report[J]. Chirurgia (Bucur), 2015, 110(3): 300-7. https://www.researchgate.net/publication/279966706_Giant_Esophageal_GIST_Diagnostic_and_Therapeutic_Challenge_-_Case_Report
[12] Zhang FB, Shi HC, Shu YS, et al. Diagnosis and surgical treatment Of esophageal gastrointestinal stromal tumors[J]. World J Gastroenterol, 2015, 21(18): 5630-4. doi: 10.3748/wjg.v21.i18.5630
[13] Kim SG. Interpretation of Pathologic Margin after Endoscopic Resection of Gastrointestinal Stromal Tumor[J]. Clin Endosc, 2016, 49(3): 229-31. doi: 10.5946/ce.2016.035
[14] Ye LP, Zhang Y, Mao XL, et al. Submucosal tunnelling endoscopic resection for the treatment of esophageal submucosal tumours originating from the muscularis propria layer: an analysis of 15 cases[J]. Dig Liver Dis, 2013, 45(2): 119-23. doi: 10.1016/j.dld.2012.08.010
[15] Navarrete A, Momblan D, Fernandez-Esparrach G, et al. Endoscopic full-thickness resection of esophagogastric junction Gastrointestinal stromal tumorassisted by laparoscopy after neoadjuvant therapy[J]. Endoscopy, 2016, 48 Suppl 1: E112-4. https://www.researchgate.net/publication/299395618_Endoscopic_full-thickness_resection_of_esophagogastric_junction_gastrointestinal_stromal_tumor_assisted_by_laparoscopy_after_neoadjuvant_therapy
[16] Isaka T, Kanzaki M, Onuki T. Long-term survival after thoracoscopic enucleation of a gastrointestinal stromal tumor arising from the esophagus[J]. J Surg Case Rep, 2015, 2015(2). pii: rju155.
[17] Robb WB, Bruyere E, Amielh D, et al. Esophageal gastrointestinal Stromal tumor: is tumoral enucleation a viable therapeutic option?[J]. Ann Surg, 2015, 261(1): 117-24. doi: 10.1097/SLA.0000000000000505
[18] 刘连科, 孙婧, 邵明雯, 等.食管癌合并胃间质瘤患者的临床病理分析 (附14例报告)[J].南京医科大学学报 (自然科学版), 2014, 34(5): 669-71. http://www.cnki.com.cn/Article/CJFDTOTAL-NJYK201405030.htm Liu Lk, Sun J, Shao MW, et al. Clinical pathological features of esophageal cancer complicated with gastric stromal tumor patients (14 cases report)[J]. Nanajing Yi Ke Da Xue Xue Bao (Zi Ran Ke Xue Ban), 2014, 34(5): 669-71. http://www.cnki.com.cn/Article/CJFDTOTAL-NJYK201405030.htm
[19] Sun X, Zou Y, Hao Y, et al. Pathological analysis of collision (double primary) cancer in the upper digestive tract concomitant with gastric stromaltumor: a case report[J]. Int J Clin Exp Pathol, 2015, 8(10): 13523-7. http://www.ijcep.com/files/ijcep0010321.pdf
[20] Qian T, Gao F, Chen MZ, et al. Collision tumor of the esophagus: report of a case with mixed squamous cell carcinoma and gastrointestinal stromal tumor[J]. Int J Clin Exp Pathol, 2014, 7(3): 1206-11. https://www.researchgate.net/publication/261328311_Collision_tumor_of_the_esophagus_Report_of_a_case_with_mixed_squamous_cell_carcinoma_and_gastrointestinal_stromal_tumor
[21] Bouchet S, Poulette S, Titier K, et al. Relationship between imatinib trough concentration and outcomes in the treatment of advanced gastrointestinal stromal tumours in a real-life setting[J]. Eur J Cancer, 2016, 57: 31-8. doi: 10.1016/j.ejca.2015.12.029
[22] 史一楠, 梁小波.胃肠间质瘤的伊马替尼新辅助治疗及手术时机的选择[J].中华胃肠外科杂志, 2015, 18(4): 313-5. http://cdmd.cnki.com.cn/Article/CDMD-12121-1016261096.htm Shi YN, Liang XB. Neoadjuvant therapy of imatinib in gastrointestinal stromal tumors and the timing of surgery[J]. Zhonghua Wei Chang Wai Ke Za Zhi, 2015, 18(4): 313-5. http://cdmd.cnki.com.cn/Article/CDMD-12121-1016261096.htm
[23] Watson GA, Kelly D, Melland-Smith M, et al. Get the GIST? An overview of gastrointestinal stromal tumours[J]. Ir J Med Sci, 2016, 185(2): 319-26. doi: 10.1007/s11845-016-1410-1
[24] Ben Ami E, Demetri GD. A safety evaluation of imatinib mesylate in the treatment of gastrointestinal stromal tumor[J]. Expert Opin Drug Saf, 2016, 15(4): 571-8. doi: 10.1517/14740338.2016.1152258
[25] Hompland I, Bruland ØS. Can Imatinib Be Safely Withdrawn in Patients with Surgically Resected Metastatic GIST?[J]. Anticancer Res, 2015, 35(11): 5759-65. https://www.researchgate.net/publication/284738537_Can_Imatinib_Be_Safely_Withdrawn_in_Patients_with_Surgically_Resected_Metastatic_GIST
[26] Rubió-Casadevall J, Martinez-Trufero J, Garcia-Albeniz X, et al. Role of surgery in patients with recurrent, metastatic, or unresectable locally advanced gastrointestinal stromal tumors sensitive to imatinib: a retrospective analysis of the Spanish Group for Research on Sarcoma (GEIS)[J]. Ann Surg Oncol, 2015, 22(9): 2948-57. doi: 10.1245/s10434-014-4360-8
[27] Keung EZ, Fairweather M, Raut CP. The Role of Surgery in Metastatic Gastrointestinal Stromal Tumors[J]. Curr Treat Options Oncol, 2016, 17(2): 8. doi: 10.1007/s11864-015-0384-y
[28] Nishida T, Blay JY, Hirota S, et al. The standard diagnosis, treatment, and follow-up of gastrointestinal stromal tumors based on guidelines[J]. Gastric Cancer, 2016, 19(1): 3-14. doi: 10.1007/s10120-015-0526-8
[29] 陈家驹, 沈朝勇, 陈卉娇, 等. 179例胃肠间质瘤临床病理特征及基因突变类型分析[J].四川大学学报 (医学版), 2016, 47(2): 275-8, 282. http://www.cnki.com.cn/Article/CJFDTOTAL-HXYK201602029.htm Chen JJ, Shen CY, Chen HJ, et al. Characteristics of Clinicopathology and Genotype in 179 Cases with Gastrointestinal Stromal Tumor[J]. Sichuan Da Xue Xue Bao (Yi Xue Ban), 2016, 47(2): 275-8, 282. http://www.cnki.com.cn/Article/CJFDTOTAL-HXYK201602029.htm
[30] Pogorzelski M, Falkenhorst J, Bauer S. Molecular subtypes of gastrointestinal stromal tumor requiring specific treatments[J]. Curr Opin Oncol, 2016, 28(4): 331-7. doi: 10.1097/CCO.0000000000000303
[31] Wada N, Kurokawa Y, Takahashi T, et al. Detecting Secondary C-KIT Mutations in the Peripheral Blood of Patients with Imatinib-Resistant Gastrointestinal Stromal Tumor[J]. Oncology, 2016, 90(2): 112-7. doi: 10.1159/000442948
[32] Park SR, Ryu MH, Ryoo BY, et al. Severe Imatinib-Associated Skin Rash In Gastrointestinal Stromal Tumor Patients: Management and Clinical Implications[J]. Cancer Res Treat, 2016, 48(1): 162-70. doi: 10.4143/crt.2015.017
计量
- 文章访问数: 1212
- HTML全文浏览量: 348
- PDF下载量: 740
下载:
